The frequency of rotating injection sites for semaglutide can depend on the recommendations provided by your healthcare professional or prescribing information for the medication
doi:10.1111/j.1365-2982.2008.01246.x Amato A, Cinci L, Rotondo A, et al
In a statement, Novo Nordisk, maker of the GLP-1 drug semaglutide, noted, For Wegovy specifically, animal studies suggest there may be risks to the fetus, and weight loss during pregnancy offers no benefit and may cause harm
Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: A prospective cohort study
Along those lines, we should note that we have come across several negative reviews pertaining to the brands customer service